These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2286464)

  • 1. Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity.
    Bergan T
    Infection; 1990; 18 Suppl 2():S65-9. PubMed ID: 2286464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison between fosfomycin and other phosphonic acid derivatives.
    Bergan T
    Chemotherapy; 1990; 36 Suppl 1():10-8. PubMed ID: 2085981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profile of fosfomycin trometamol.
    Bergan T; Thorsteinsson SB; Albini E
    Chemotherapy; 1993; 39(5):297-301. PubMed ID: 8370321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative bioavailability of fosfomycin and of trometamol after administration of single dose by oral route of fosfomycin trometamol in fasting conditions and after a meal.
    Borgia M; Longo A; Lodola E
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):411-7. PubMed ID: 2793277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fosfomycin-trometamol (monuril): pharmacokinetics and food-drug interactions].
    Muller-Serieys C; Bergogne-Berezin E; Joly-Guillou ML
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):753-6. PubMed ID: 3309810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pharmacokinetics of tromethamine fosfomycin and calcium fosfomycin in young and elderly adults.
    Borsa F; Leroy A; Fillastre JP; Godin M; Moulin B
    Antimicrob Agents Chemother; 1988 Jun; 32(6):938-41. PubMed ID: 3415215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trometamol-fosfomycin (Monuril) bioavailability and food-drug interaction.
    Bergogne-Bérézin E; Muller-Serieys C; Joly-Guillou ML; Dronne N
    Eur Urol; 1987; 13 Suppl 1():64-8. PubMed ID: 3569381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of trometamol-fosfomycin in patients with renal insufficiency].
    Fillastre JP; Leroy A; Josse S; Moulin B
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):728-30. PubMed ID: 3054756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of fosfomycin trometamol (Monuril).
    Segre G; Bianchi E; Cataldi A; Zannini G
    Eur Urol; 1987; 13 Suppl 1():56-63. PubMed ID: 3569380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High interindividual variability in urinary fosfomycin concentrations in healthy female volunteers.
    Wijma RA; Koch BCP; van Gelder T; Mouton JW
    Clin Microbiol Infect; 2018 May; 24(5):528-532. PubMed ID: 28867662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.
    Wenzler E; Ellis-Grosse EJ; Rodvold KA
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary concentrations of fosfomycin after a single 3 g dose of fosfomycin to elderly nursing-home patients.
    Janknegt R; Hooymans PM; Fabius GT; Nohlmans-Paulssen MK; Machielsen C; Boogaard-van den Born J; Rang J; Smits CA; Willems-Thissen ME; Krommenhoek A
    Pharm World Sci; 1994 Jun; 16(3):149-53. PubMed ID: 7920366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fosfomycin trometamol: multiple-dose regimen for the treatment of lower urinary tract infections].
    Sádaba-Díaz de Rada B; Azanza-Perea JR; García-Quetglas E; Honorato-Pérez J
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):546-50. PubMed ID: 17125672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fosfomycin trometamol: historical background and clinical development.
    Gialdroni Grassi G
    Infection; 1990; 18 Suppl 2():S57-9. PubMed ID: 2286462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt.
    Scaglione F; Cicchetti F; Demartini G; Arcidiacono M
    Int J Clin Pharmacol Res; 1994; 14(3):107-9. PubMed ID: 7883387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial activity in human urine of fosfomycin trometamol in an in vitro model of the urinary bladder.
    Dubini F; Riviera L
    Chemioterapia; 1988 Feb; 7(1):15-9. PubMed ID: 3259909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin trometamol: activity in vitro against urinary tract pathogens.
    Greenwood D
    Infection; 1990; 18 Suppl 2():S60-4. PubMed ID: 2286463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections.
    Patel SS; Balfour JA; Bryson HM
    Drugs; 1997 Apr; 53(4):637-56. PubMed ID: 9098664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic study of fosfomycin and its bioavailability.
    Cadórniga R; Diaz Fierros M; Olay T
    Chemotherapy; 1977; 23 Suppl 1():159-74. PubMed ID: 832511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of fosfomycin in chickens after a single intravenous dose and tissue levels following chronic oral administration.
    Aramayona JJ; Bregante MA; Solans C; Rueda S; Fraile LJ; Garcia MA
    Vet Res; 1997; 28(6):581-8. PubMed ID: 9428152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.